e-learning
resources
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A randomised trial of
Mycobacterium w
in critically ill patients with COVID-19: ARMY-1
Inderpaul Singh Sehgal, Randeep Guleria, Sarman Singh, Mohammad Sabah Siddiqui, Ritesh Agarwal
Source:
ERJ Open Res, 7 (2) 00059-2021; 10.1183/23120541.00059-2021
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Inderpaul Singh Sehgal, Randeep Guleria, Sarman Singh, Mohammad Sabah Siddiqui, Ritesh Agarwal. A randomised trial of
Mycobacterium w
in critically ill patients with COVID-19: ARMY-1. ERJ Open Res, 7 (2) 00059-2021; 10.1183/23120541.00059-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Classification and effectiveness of different oxygenation goals in mechanically ventilated critically ill patients: network meta-analysis of randomised controlled trials
Source: Eur Respir J, 58 (3) 2002928; 10.1183/13993003.02928-2020
Year: 2021
Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure:
post hoc
analysis of a randomised clinical trial
Source: ERJ Open Res, 7 (4) 00418-2021; 10.1183/23120541.00418-2021
Year: 2021
Serum bilirubin/fetuin-A ratio in critically ill septic patients: a prospective study
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
Positive effect of MusiCure on patients undergoing bronchochoscopy - A randomized controlled trial
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova
Source: Eur Respir J, 56 (2) 2000493; 10.1183/13993003.00493-2020
Year: 2020
Effects of neuromuscular electrical stimulation in critically ill patients by assessment with peak torque evoked: A randomized controlled trial
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016
Free leptin index in critically ill septic patients: a prospective case-control study
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Telehealth vs. standard care in COPD – a randomized controlled trial
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial)
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021
Home care combining oral nutritional supplement, exercise and androgen substitution in malnourished patients with chronic respiratory failure: a prospective controlled randomized multicenter trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial
Source: Eur Respir J, 53 (4) 1801530; 10.1183/13993003.01530-2018
Year: 2019
Effect of ADL- training for persons with COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021
Quality of life of patients with stable COPD receiving outpatient care of a respiratory nurse: a randomised controlled trial
Source: Annual Congress 2003 - Education for asthma patients and different aspects concerning COPD
Year: 2003
Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Source: ERJ Open Res 2016: 00055-2016
Year: 2016
Alterations in serum lipid profile in critically ill septic patients: a prospective study
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014
Outpatient vs. home-based pulmonary rehabilitation in COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept